SEGUNDO SIMPOSIO EURORDIS”MEJORANDO EL ACCESO A TERAPIAS DE PACIENTES CON ENFERMEDADES RARAS”

BAJO EL HASHTAG #RareEU2017 PODRÁ SEGUIR EN DIRECTO TODA LA JORNADA.
22 February, 9:00 – 13:00 CET

Take part in an interactive
event bringing together patient advocates, payers, HTA bodies, academics, clinicians, policy makers, investors and industry representatives to work together to improve patients’ access to rare disease therapies.

The opening session of this symposium will be live web streamed. Take part in polls or ask questions via eurordis.org/live. You can also ask questions via Twitter using #RareEU2017.
2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies
22 – 23 February 2017. Hotel Le Plaza, Brussels, Belgium

Would you like to be a part of a truly multi-stakeholder process aiming to establish sustainable and long-lasting solutions to improve patients’ access to rare disease therapies?

This Symposium on improving patient access to rare disease therapies will bring together patient advocates, payers, HTA bodies, academics, clinicians, policy makers, investors and industry representatives. It will enable participants to understand the interests and challenges of each stakeholder group, to discuss current and emerging initiatives and to continue to work together to improve patients’ access to rare disease therapies.

See the advanced programme and more information (venue, travel & accommodation, programme committee and official partners).

Please note that the language of this event is English.

Should you have any questions concerning your registration, please contact emilie.zingg@eurordis.org

Anuncios

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión / Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión / Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión / Cambiar )

Google+ photo

Estás comentando usando tu cuenta de Google+. Cerrar sesión / Cambiar )

Conectando a %s